The vast majority of research studies working to identify risk factors and prediction models for preeclampsia are focused on the pregnant woman. But what about the other half of the "placental equation"? Researchers for this study suggest that paternal health (meaning the health of the man that contributed the sperm and half the genes to the placenta and baby) should be considered when evaluating a patient’s risk for preeclampsia, too. In this study, researchers asked if paternal health – classified by characteristics of the metabolic syndrome (large waist circumference, high triglycerides, low HDL (the “good” cholesterol), increased blood pressure, and elevated blood sugar) - are linked to maternal health during pregnancy.
Researchers analyzed pregnancy outcomes in over 650,000 healthy women in the IBM Marketscan® research database (which also included data on paternal health) and found a strong relationship between likelihood of preeclampsia and a partner with 2 or more characteristics of the metabolic syndrome. The odds of preeclampsia were 21% higher for women with partners with 2 or more of these characteristics compared to women with partners with none. That means that where 5 out of 100 average women will develop preeclampsia during pregnancy, 6 out of 100 women with partners with metabolic syndrome will. This study shows that in healthy, low risk women, prepregnancy paternal health may be worth assessing to make medical decisions about prenatal care.
LINK: https://pubmed.ncbi.nlm.nih.gov/33895399/
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Placental dysfunction can result in conditions such as preeclampsia, which have traditionally been managed with close monitoring and appropriately timed delivery. There is currently no cure for preecl...
Gestational hypertension continues to be a growing public health concern contributing to maternal morbidity, mortality, and long-term health complications in the U.S. While changes in vision—suc...
Background Low-dose aspirin (81 mg) is a treatment known to help lower the risk of preeclampsia. However, not everyone who is at higher risk is told to take it. This study looks at whether a screening...
Women who experienced Preeclampsia have a higher lifetime risk of developing cardiovascular disease (CVD) than women who did not suffer from this pregnancy complication. Researchers wanted to know if...
Recent findings in preeclampsia research have shown that preeclampsia likely has at least two variants – an early onset and a late onset variant. Early onset is typically defined as before 34 we...
